1,1-Cyclopropanedicarboxylic Acidum CAS 598-10-7 Puritas >98.0% (GC) (T)

Description:

Nomen chemica: 1,1-Cyclopropanedicarboxylic Acid

Synonyma: Cyclopropane-1,1-Dicarboxylic Acidum

CAS: 598-10-7

Puritas: >98.0% (GC) (T)

Aspectus: Alba vel Off-White pulveris

Contactus: Dr

Mobile/Wechat/Whatsapp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Shanghai Ruifu Chemical Co, Ltd. est primarius fabrica et supplementum 1,1-cyclopropanedicarboxylici acidum (CAS: 598-10-7) cum qualitate magna.CoA praebere possumus, totius orbis partus, parvas et parvas quantitates in promptu habentes.Si interesse in hoc facto, singula informationes mittas mitte nobis numerum CAS, nomen productum, quantitatem nobis.Please contact: alvin@ruifuchem.com

Chemical Properties:

Nomen chemicum 1,1-Cyclopropanedicarboxylic Acid
Synonyma Cyclopropane-1,1-Dicarboxylic Acid;1,1-Cyclopropanedicarboxylate;1,1-Cyclopropane-2,2,3,3-d4-Dicarboxylic Acid
CAS Number 598-10-7
CATTUS Number RF2882
Stock Status In Stock, Productio Capacity 20 Tons per Month
Formulae hypotheticae C5H6O4
M. Pondus 130.10
Liquescens punctum 1300~ 138.0℃
Solubilitas in aqua Solubilis in aqua, pusillanimitas
Aleam Nota Irritant
Periculum Classis 8
Stipare Group III
HS Code* 29172090
Fasciae vita Annis II
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba vel Off-White pulveris
Puritas / Analysis Methodus >98.0% (GC)
Puritas / Analysis Methodus > 98.0% (Titration Neutralization)
Liquescens punctum 1300~ 138.0℃
Aqua (auctore Karl Fischer) <0.50%
Totalis immunditias <2.00%
1 H NMR Spectrum Congruunt cum Structure
Solubilitas in H2O Valde seditiosa Turbidity Transi
Test Standard Enterprise Standard
Consuetudinem Pharmaceutical Intermedia;Cabozantinib immunditia

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

Satis capacitas: sufficientes facilities et technici

Professional Service: One stop acquireing service

Altera Package: Custom sarcina ac titulus praesto

Ieiunium Delivery: Si intra stirpem, tres dies partus praestatur

Supple firmum: Esse rationabile stirpe

Technical Support: Technology solution praesto

Custom Synthesis Service: Range from P. to kilos

High Quality: Constitutus ratio completa qualitas certitudinis

FAQ:

Quam mercari?Quaeso contactumDr. Alvin Huang: sales@ruifuchem.com or alvin@ruifuchem.com 

15 Years Experience?Plus quam XV annos experientiae habemus in fabricando et exportando amplis intermediis pharmaceuticis vel alchimicis pharmaceuticis amplis.

Mercatus principalis?Vendere mercatum domesticum, Americam septentrionalem, Europam, Indiam, Coream, Iaponicam, Australiam etc.

Commodi?Superior qualitas, parabilis pretium, officia professionalia et subsidia technica, ieiunium partus.

Qualitasfides?Qualitas strictioris temperantiae ratio.Pro instrumento analysi professionali includuntur NMR, LC-MS, GC, HPLC, ICP-MS, UV, IR, OR, KF, ROI, LOD, MP, Claritas, Solubilitas, Microbialis limes test, etc.

Exempla?Pleraque producta praebent exempla gratuita pro qualitate aestimationis, sumptus naviculas a clientibus solvendos.

Factory Audit?Factory audit gratissimum.Quaeso ante constitutum.

MOQ?Nec MOQ.Parvus ordo placet.

Tempus adferendi? Si intus prosapia, tres dies partus praestatur.

Transportatio?Per Express (FedEx, DHL), ab Air, per Mare.

Documenta?Post servitium venditionis: COA, MOA, ROS, MSDS, etc. praeberi possunt.

Consuetudo Synthesis?Consuetudo synthesis officia praebere potest ad optimas investigationes tuas necessitates aptandas.

Pensio conditio?Proforma cautionis primum post confirmationem ordinis mittetur, informationes nostrae ripae inclusas.Payment by T/T (Telex Transfer), PayPal, Western Union, etc.

Applicatio:

1,1-Cyclopropanedicarboxylicum Acidum (CAS: 598-10-7) est Acidum dicarboxylicum.Est medium seu immunditia Cabozantinib (CAS: 849217-68-1).Cabozantinib est novum genus medicamentorum hypotheticorum iaculis enucleatum ab Exelixis Americae Foederatae societatis biopharmaceuticae.Die XXIX mensis Novembris anno MMXII, Cibus US et Administration medicamentis (FDA) usum cabozantinib approbavit ad curationem loci maligni incomprehensibilis vel metastatici thyreoidis carcinomatis medullaris.1,1 - Acidum cyclopropanedicarboxylicum etiam in parandis intermediis Montelukast et Ketorolac adhibetur.Adhibetur ad metallocyclos parandos spiro-cyclopropyl.1,1 - Acidum cyclopropanedicarboxylicum adhibitum est in praeparandis novis derivationibus heterocyclicis acidi dicarboxylici cyclopropanei thiadiazoli et 1,2, 4-triazoli continens medietatem.Etiam usus est ad metallocyclos spiro-cyclopropyl praeparandos.Potest etiam adhiberi ut scandalum aedificium pro synthesi seriei cyclopropanecarboxamidis, habens actionem antifungalam.

Epistulam tuam hic scribe et mitte nobis